Support
Changes in Medicare Prescription Drug Legislation
September 2, 2003
The Issue at Hand
This is an
update from our July 11 Alert.
On
June 26, the House and Senate passed Medicare prescription
drug bills (S.1/H.R.1) that would make significant changes
in Medicare’s program structure and benefits. With the
two bills now in a difficult conference committee phase,
the National Association of Social Workers (NASW) is
seeking to make improvements in the final bill by supporting
a number of policies to address the shortcomings. Please
see our July 11 Alert at https://www.socialworkers.org/advocacy/alerts/071103_alert.asp
Each version has
positive elements in potentially lowering the cost of outpatient
prescriptions for millions of older and disabled Americans — especially
those with low incomes and with very high drug expenses.
However, both bills are inadequate as they contain major
gaps in coverage. Additionally, the gaps could lead to unaffordable
increases in cost sharing requirements and to loss of insurance
coverage from former or current employers. Provisions in
the House bill that offer incentives for beneficiaries to
enroll in private plans, which would ultimately set in motion
a Medicare financing death spiral pose a grave concern.
The bill is
at a critical juncture.
House
and Senate conferees left for their August recess with
many unresolved substantive issues, such as how to structure
the drug benefit through health insurance plans and how
to subsidize low-income seniors. Many lawmakers and experts
believe that the bill’s passage may be in serious jeopardy,
because conference committee members remain far apart
on several key issues. While Congress reconvenes this
week, no date has been set for the next conference committee
meeting.
Action Needed
Send an e-mail
or fax to your Senators and Representatives immediately with
the sample message that appears on NASW’s Congress Web
at http://63.66.87.48/cweb4/index.cfm?orgcode=NASW (the
letter can be downloaded and edited). For your Senators’ or
Representatives’ fax numbers – call the Capitol Switchboard
(202-225-3121).
Ask your Senators
and Representatives to contact the conferees from their
own parties to convey their support for your position. The
conferees are:
House Republicans |
House Democrats |
Michael Bilirakis (FL)
Tom DeLay (TX)
Nancy Johnson (CT)
Billy Tauzin (LA)
Bill Thomas (CA)
|
Sherrod Brown (OH)
John Dingell (MI)
Charles Rangle (NY)
|
| |
|
Senate Republicans |
Senate Democrats |
Bill Frist (TN)
Charles Grassley (IA)
Orrin Hatch (UT)
Jon Kyl (AZ)
Don Nickles (OK)
|
Max Baucus (MT)
John Breaux (LA)
Tom Daschle (SD)
Jay Rockefeller (WV) |
Changes Sought in Final Bill
NASW is concerned
about key provisions of S.1/H.R.1, which have the potential
to greatly harm the program and its future beneficiaries.
Following is an outline of the priority corrections for the
final version, which we explained in more detail in the July
11 alert. https://www.socialworkers.org/advocacy/alerts/071103_alert.asp
Privatization
must not undermine the basic fee for service program.
The House bill requires
that the traditional fee for service Medicare program compete
against private plans, based on price, beginning in 2010.
Ultimately, this could result in the dismantling of Medicare
as a universal entitlement.
Increases
in premiums and deductibles must be affordable.
Both bills add burdensome
new deductibles and co-payments to traditional Medicare and
the new prescription drug benefit.
Benefits must
not be means tested.
Medicare reform
must not include means testing. Relying on income levels
to determine access to Medicare benefits would severely undermine
Medicare's universal nature and fairness.
Benefits must
apply equally to Medicaid dual eligible persons.
The Senate bill
does not offer the Medicare drug benefit to seniors who are
eligible for Medicaid. The House bill would slowly phase
in the benefit for Medicaid and Medicare dual eligible persons.
Prescription
drug coverage must be adequate.
The gap in drug
coverage in both bills must be reduced. Many beneficiaries
cannot afford to pay 100 percent of their drug costs between
the basic benefit cap ($2,001 in the House and $4,501 in
the Senate) and the catastrophic drug stop loss ($4,900 in
the House and $5,813 in the Senate).
A reliable
federal fallback program is essential.
Both bills create
access to drug benefits through private plans. In rural areas,
where few health plans may wish to market the new private
plans, the Senate bill creates a federal fallback plan to
ensure benefits remain available. Under the House plan, availability
will be up to the private sector.
Timing
The time to
contact your legislators is now.
There
is uncertainty about how long the conference committee
negotiations will last. Many expect consideration to
continue well into October, although this is speculative.
NASW will be advocating for these policy outcomes throughout
the conference, targeting members of Congress — particularly
the conferees — for
grassroots action. Once we see the conference agreement,
NASW will develop a position on whether or not to support
final passage.
THANKS
FOR YOUR ADVOCACY!
If you have questions or need
additional materials, please contact Enzo Pastore, NASW
senior government relations associate, at epastore@naswdc.org or
202.336.8336. |